Others have shown that, while inhibition of BCL-2 family proteins can significantly induce MCC cell death [43], BCL-2 antisense therapy alone was insufficient to inhibit tumor growth in patients with advanced MCC [33]). The gene discussed is BCL2; the disease is Merkel cell skin cancer.